Carbamazepine (Tegretol) in epilepsy. Nine year follow-up study with special emphasis on untoward reactions.
Livingston
S
S
Department of Pediatrics, Johns Hopkins University School of Medicine, The Johns Hopkins Hospital Epilepsy Clinic, Baltimore, Maryland 21205, USA.
Pauli
L L
LL
Berman
W
W
D000293:Adolescent; D000328:Adult; D000469:Alkaline Phosphatase / Q000097:blood; D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use*; D002220:Carbamazepine / Q000009:adverse effects* / Q000627:therapeutic use*; D002648:Child; D004172:Diplopia / Q000139:chemically induced; D062787:Drug Overdose; D004827:Epilepsy / Q000188:drug therapy*; D005076:Exanthema / Q000139:chemically induced; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D012720:Severity of Illness Index; D012894:Sleep Stages
D000927:Anticonvulsants; D002220:Carbamazepine; D000469:Alkaline Phosphatase